RNase L mediates the antiviral effect of interferon through a selective reduction in viral RNA during encephalomyocarditis virus infection

The 2',5'-oligoadenylate (2-5A) system is an RNA degradation pathway which plays an important role in the antipicornavirus effects of interferon (IFN), RNase L, the terminal component of the 2-5A system, is thought to mediate this antiviral activity through the degradation of viral RNA; how el er, the capacity of RNase L to selectively target viral RNA has not been carefully examined in intact cells, Therefore, the mechanism of RNase L-mediated antiviral activity was investigated following encephalomyocarditis virus (EMCV) infection of cell lines in which expression of transfected RNase L was induced or endogenous RNase L activity was inhibited, RNase L induction markedly enhanced the anti-EMCV: activity of IFN via a reduction in EMCV RNA, Inhibition of endogenous RNase L activity; inhibited this reduction in viral RNA, RNase L had no effect on IFN-mediated protection from vesicular stomatitis, virus. RNase L induction reduced the rate of EMCV RN,I synthesis, suggesting that RNase L may target viral RNAs involved in replication early in the virus life cycle. The RNase L-mediated reduction in viral RNA occurred in the absence of detectable effects on specific cellular mRNAs and without any global alteration in the cellular RNA profile, Extensive rRNA cleavage, indicative of high levels of 2-5A, was not observed in RNase L-induced, EMCV-infected cells; however, transfection of 2-5A into cells resulted in widespread degradation of cellular RNAs, These findings proc ide the first demonstration of the selective capacity of RNase L in intact cells and link this selective activity to cellular levels of 2-5A.